Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years
NCT05138705
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
380
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza, Human
Interventions
BIOLOGICAL:
Quadrivalent Influenza Virus Split Vaccine
Sponsor
Shanghai Institute Of Biological Products